- English (USA)
- English (UK)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Galapagos NV (GLPG)Galapagos NV stock price live, this page displays AS GLPG stock exchange data. View the GLPG premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Galapagos NV real time stock price chart below.
What Is the Galapagos NV Stock Price Today?
The Galapagos NV stock price today is 26.26.
What Is the Stock Symbol for Galapagos NV?
The stock symbol for Galapagos NV is "GLPG."
What Stock Exchange Does Galapagos NV Trade On?
Galapagos NV is listed and trades on the Amsterdam stock exchange.
Is Galapagos NV a Good Stock to Buy?
Determining whether Galapagos NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLPG quote. (ISIN: BE0003818359)
What Is the Galapagos NV Stock Price Today?
The Galapagos NV stock price today is 26.26.
What Is the Stock Symbol for Galapagos NV?
The stock symbol for Galapagos NV is "GLPG."
What Stock Exchange Does Galapagos NV Trade On?
Galapagos NV is listed and trades on the Amsterdam stock exchange.
Is Galapagos NV a Good Stock to Buy?
Determining whether Galapagos NV—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the GLPG quote. (ISIN: BE0003818359)
26.26
+0.12(+0.46%)
Closed
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.04
26.42
52 wk Range
22.00
39.00
GLPG Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
26.0426.42
52 wk Range
22.0039.00
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockGLPG Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Technical Analysis
Strong Buy
Analysts Sentiment
Neutral
Price Target
35.37
Upside
+34.69%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
Galapagos Company Profile
Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company’s pipeline products comprise GLPG3667 that has completed phase 1b trial; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; GLPG5201, a CD19 CAR-T product candidates manufactured at point-of-care, currently in phase 1/2 trial in replapsed/refractory chronic lymphocytic leukemia; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc.; and AbbVie S.à r.l. Galapagos NV was incorporated in 1999 and is headquartered in Mechelen, Belgium.
Compare GLPG to Peers and Sector
Metrics to compare | GLPG | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipGLPGPeersSector | |
|---|---|---|---|---|
P/E Ratio | −28.6x | −1.1x | −0.7x | |
PEG Ratio | −0.12 | −0.05 | 0.00 | |
Price/Book | 0.6x | 1.7x | 2.6x | |
Price / LTM Sales | 6.7x | 5.5x | 3.2x | |
Upside (Analyst Target) | 14.2% | 91.5% | 40.8% | |
Fair Value Upside | Unlock | 5.1% | 5.7% | Unlock |
Analysts' Recommendations
1 Buy
8 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 35.37
(+34.68% Upside)
FAQ
What Is the Galapagos (GLPG) Stock Price Today?
The Galapagos stock price today is 26.26.
What Stock Exchange Does Galapagos Trade On?
Galapagos is listed and trades on the Amsterdam stock exchange.
What Is the Stock Symbol for Galapagos?
The stock symbol for Galapagos is "GLPG."
What Is the Galapagos Market Cap?
As of today, Galapagos market cap is 1.73B.
What is Galapagos Earnings Per Share?
The Galapagos EPS is 3.14.
What Is the Next Galapagos Earnings Date?
Galapagos will release its next earnings report on 11 Feb 2025.
From a Technical Analysis Perspective, Is GLPG a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.